A study on regulatory mechanism of miR-223 in ulcerative colitis through PI3K/Akt-mTOR signaling pathway

W Jiang1, Y-P Han, M Hu

  • 1Department of Gastroenterology, First Affiliated Hospital of Jiamusi University, Jiamusi, China. dncc_321@163.com.

Abstract

Insights

MicroRNA-223 (miR-223) exacerbates ulcerative colitis (UC) by activating the PI3K/Akt-mTOR pathway, leading to increased inflammation and cell apoptosis. Inhibiting miR-223 shows therapeutic potential in UC models.

Area of Science:

  • Molecular Biology
  • Gastroenterology
  • Immunology

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease with complex regulatory mechanisms.
  • MicroRNAs (miRNAs) play crucial roles in inflammatory diseases, but their specific roles in UC require further elucidation.
  • The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)-mammalian target of rapamycin (mTOR) signaling pathway is implicated in cell proliferation, survival, and inflammation.

Purpose of the Study:

  • To investigate the regulatory role of microRNA-223 (miR-223) in ulcerative colitis (UC).
  • To explore the involvement of the PI3K/Akt-mTOR signaling pathway in miR-223-mediated UC pathogenesis.
  • To assess the therapeutic potential of targeting miR-223 in a rat model of UC.

Main Methods:

  • Establishment of a UC rat model.
  • Treatment with a miR-223 inhibitor in a subset of UC rats.
  • Assessment of mTOR expression via immunohistochemistry.
  • Quantification of PI3K/Akt pathway proteins (P85, P110, p-Akt) using Western blotting.
  • Measurement of miR-223 mRNA levels via quantitative polymerase chain reaction (qPCR).
  • Evaluation of cell apoptosis using TUNEL assay.
  • Determination of inflammatory cytokine levels (IL-1β, IL-6) via ELISA.

Main Results:

  • UC induction led to increased mTOR, P85, P110, p-Akt, miR-223, IL-1β, IL-6, and cell apoptosis.
  • Inhibition of miR-223 significantly reduced mTOR, P85, P110, p-Akt, IL-1β, IL-6, and cell apoptosis.
  • While miR-223 expression was elevated in UC, its levels did not significantly change between UC and miR-223 inhibitor groups, suggesting miR-223 acts upstream or parallel to the inhibitor's direct effect on the pathway.

Conclusions:

  • MiR-223 promotes cell apoptosis and inflammation in ulcerative colitis.
  • These effects are mediated through the up-regulation of the PI3K/Akt-mTOR signaling pathway.
  • Targeting miR-223 demonstrates therapeutic promise for managing UC.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
940
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
481
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K